JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 48 filers reported holding JANUX THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,939 | -92.8% | 490 | -91.5% | 0.00% | – |
| Q2 2023 | $68,691 | +915.5% | 5,787 | +935.2% | 0.00% | – |
| Q1 2023 | $6,764 | +29.4% | 559 | +40.8% | 0.00% | – |
| Q4 2022 | $5,228 | -59.8% | 397 | -59.7% | 0.00% | – |
| Q3 2022 | $13,000 | -50.0% | 985 | -54.2% | 0.00% | – |
| Q2 2022 | $26,000 | -3.7% | 2,151 | +16.3% | 0.00% | – |
| Q1 2022 | $27,000 | -71.3% | 1,850 | -61.3% | 0.00% | – |
| Q4 2021 | $94,000 | +147.4% | 4,784 | +172.6% | 0.00% | – |
| Q3 2021 | $38,000 | -98.2% | 1,755 | -98.0% | 0.00% | -100.0% |
| Q2 2021 | $2,163,000 | – | 86,695 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 8,670,644 | $105,869,000 | 2.82% |
| 5AM Venture Management, LLC | 446,266 | $5,449,000 | 1.35% |
| Samsara BioCapital, LLC | 360,414 | $4,401,000 | 1.17% |
| BVF INC/IL | 1,470,334 | $17,953,000 | 0.87% |
| Orbimed Advisors | 2,836,386 | $34,632,000 | 0.63% |
| EcoR1 Capital, LLC | 1,421,319 | $17,354,000 | 0.60% |
| Parkwood LLC | 33,750 | $412,000 | 0.07% |
| Woodline Partners LP | 286,383 | $3,497,000 | 0.05% |
| Cerity Partners LLC | 150,933 | $1,843,000 | 0.02% |
| JANUS HENDERSON GROUP PLC | 2,127,797 | $25,966,000 | 0.02% |